SCHEMBL30272473

SCHEMBL30272473

CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 13/20 0.55
▸ NPY1R P25929 9/20 0.55
▸ NPY5R Q15761 8/20 0.55
▸ NPY2R P49146 5/20 0.55
▸ KISS1R Q969F8 6/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31405541 0.94 BACE1 (0.55) NPY4RNPY1RNPY5RNPY2R
SCHEMBL30477221 0.93 NPY4R (0.56) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL29641576 0.93 NPY4R (0.56) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL4456143 0.92 BACE1 (0.59) KISS1R
SCHEMBL4456136 0.92 BACE1 (0.59) KISS1R
SCHEMBL30541920 0.91 GNPAT (0.52) NPY4RNPY1RNPY5RNPY2R
SCHEMBL30575415 0.91 NPY4R (0.46) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL30198934 0.88 BACE1 (0.52) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL29608079 0.87 KISS1R (0.57) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL30089310 0.87 NPY4R (0.60) NPY4RNPY1RNPY5RNPY2RKISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11628202-B2 Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia NYMOX CORPORATION (CA) 2023-04-18 — — US disclosed
Send feedback